Form 8-K - Current report:
SEC Accession No. 0001193125-26-160347
Filing Date
2026-04-17
Accepted
2026-04-17 08:02:10
Documents
11
Period of Report
2026-04-16
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d17006d8k.htm   iXBRL 8-K 26465
  Complete submission text file 0001193125-26-160347.txt   142169

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA tyra-20260416.xsd EX-101.SCH 3156
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE tyra-20260416_lab.xml EX-101.LAB 17976
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tyra-20260416_pre.xml EX-101.PRE 11242
14 EXTRACTED XBRL INSTANCE DOCUMENT d17006d8k_htm.xml XML 3629
Mailing Address 2656 STATE STREET CARLSBAD CA 92008
Business Address 2656 STATE STREET CARLSBAD CA 92008 (619) 728-4760
Tyra Biosciences, Inc. (Filer) CIK: 0001863127 (see all company filings)

EIN.: 831476348 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40800 | Film No.: 26869448
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)